Athena Cherry

Professional Education

Indiana University (1990) IN

Fellowship: Stanford Hospital and Clinics (1993) CA

Board Certification: Clinical Cytogenetics, American Board of Medical Genetics (1993)

Ph.D., Indiana University, Medical Genetics (1990)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes.
Merker, J. D., Roskin, K. M., Ng, D., Pan, C., Fisk, D. G., & Gotlib, J. (2013). Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes. Haematologica, 98(11), 1689-1696.

Hidden Mastocytosis in Acute Myeloid Leukemia With t(8;21)(q22;q22).
Johnson, R. C., Savage, N. M., Chiang, T., Gotlib, J. R., Cherry, A. M., & George, T. I. (2013). Hidden Mastocytosis in Acute Myeloid Leukemia With t(8;21)(q22;q22). American journal of clinical pathology, 140(4), 525-535.

B-Cell Transcription Factor Expression and Immunoglobulin Gene Rearrangement Frequency in Acute Myeloid Leukemia With t(8;21)(q22;q22)
Johnson, R. C., Ma, L., Cherry, A. M., Arber, D. A., & George, T. I. (2013). B-Cell Transcription Factor Expression and Immunoglobulin Gene Rearrangement Frequency in Acute Myeloid Leukemia With t(8;21)(q22;q22). AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 140(3), 355-362.

Activating HRAS Mutation in Agminated Spitz Nevi Arising in a Nevus Spilus.
Sarin, K. Y., Sun, B. K., Bangs, C. D., Cherry, A., Swetter, S. M., & Khavari, P. A. (2013). Activating HRAS Mutation in Agminated Spitz Nevi Arising in a Nevus Spilus. JAMA dermatology , 149(9), 1077-1081.

A Case Series of Lengthy Progression-Free Survival With Pemetrexed-Containing Therapy in Metastatic Non-Small-Cell Lung Cancer Patients Harboring ROS1 Gene Rearrangements.
Riess, J. W., Padda, S. K., Bangs, C. D., Das, M., Neal, J. W., & Wakelee, H. A. (2013). A Case Series of Lengthy Progression-Free Survival With Pemetrexed-Containing Therapy in Metastatic Non-Small-Cell Lung Cancer Patients Harboring ROS1 Gene Rearrangements. Clinical lung cancer, 14(5), 592-595.

Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria: A Single-Center Experience.
Davis, K. L., Marina, N., Arber, D. A., Ma, L., Cherry, A., & Heerema-McKenney, A. (2013). Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria: A Single-Center Experience. American journal of clinical pathology, 139(6), 818-825.

Clinicopathologic Characteristics of HER2 FISH-ambiguous Breast Cancer at a Single Institution
Clay, M. R., Iberri, D. J., Bangs, C. D., Cherry, A., & Jensen, K. C. (2013). Clinicopathologic Characteristics of HER2 FISH-ambiguous Breast Cancer at a Single Institution. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(1), 120-127.

Report of Two Patients and Further Characterization of Interstitial 9p13 Deletion-A Rare But Recurrent Microdeletion Syndrome?
Niemi, A.-K., Kwan, A., Hudgins, L., Cherry, A. M., & Manning, M. A. (2012). Report of Two Patients and Further Characterization of Interstitial 9p13 Deletion-A Rare But Recurrent Microdeletion Syndrome?. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 158A(9), 2328-2335.

Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
Cherry, A. M., Slovak, M. L., Campbell, L. J., Chun, K., Eclache, V., & Dewald, G. W. (2012). Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?. LEUKEMIA RESEARCH, 36(7), 832-840.

HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population: Clinicopathologic Analysis With Proposed Approach to HER2 Assessment
Kunz, P. L., Mojtahed, A., Fisher, G. A., Ford, J. M., Chang, D. T., & Pai, R. K. (2012). HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population: Clinicopathologic Analysis With Proposed Approach to HER2 Assessment. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(1), 13-24.

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells
Batista, L. Fz., Pech, Mf., Zhong, F. L., Nguyen, H. N., Xie, K. T., & Artandi, S. E. (2011). Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. NATURE, 474(7351), 399-?.

Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants
Pereira, S., Vayntrub, T., Hiraki, D. D., Cherry, A. M., Arai, S., & Grumet, F. C. (2011). Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants. HUMAN IMMUNOLOGY, 72(6), 503-509.

A Pediatric B Lineage Leukemia With Coincident MYC and MLL Translocations
Meeker, N. D., Cherry, A. M., Bangs, C. D., & Frazer, J. K. (2011). A Pediatric B Lineage Leukemia With Coincident MYC and MLL Translocations. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 33(2), 158-160.

Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization
Zhang, Z., Arora, S., Zhou, yanjiao, Cherry, A., & Wang, T. Sf. (2011). Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization. CHROMOSOMA, 120(1), 73-82.

Effects of Long-Term Culture on Human Embryonic Stem Cell Aging
Xie, X., Hiona, A., Lee, A. S., Cao, F., Huang, M., & Wu, J. C. (2011). Effects of Long-Term Culture on Human Embryonic Stem Cell Aging. STEM CELLS AND DEVELOPMENT, 20(1), 127-138.

Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
Mobley, B. C., McKenney, J. K., Bangs, C. D., Callahan, K., Yeom, K. W., & Vogel, H. (2010). Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. ACTA NEUROPATHOLOGICA, 120(6), 745-753.

Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge
Arredondo, A. R., Gotlib, J., Shier, L., Medeiros, B., Wong, K., & George, T. I. (2010). Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge. AMERICAN JOURNAL OF HEMATOLOGY, 85(8), 600-606.

Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
Medeiros, B. C., Kohrt, H. E., Arber, D. A., Bangs, C. D., Cherry, A. M., & Alizadeh, A. A. (2010). Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). LEUKEMIA RESEARCH, 34(5), 594-597.

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes
Metcalf, R. A., Zhao, S., Anderson, M. W., Lu, Z. S., Galperin, I., & Natkunam, Y. (2010). Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. MODERN PATHOLOGY, 23(3), 420-433.

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells
Sun, N., Panetta, N. J., Gupta, D. M., Wilson, K. D., Lee, A., & Wu, J. C. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(37), 15720-15725.

Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report.
Chan, S. M., George, T., Cherry, A. M., & Medeiros, B. C. (2009). Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report. Cases journal, 2(1), 121-?.

Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen
Laport, G. G., Alvarnas, J. C., Palmer, J. M., Snyder, D. S., Slovak, M. L., & Forman, S. J. (2008). Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. BLOOD, 112(3), 903-909.

Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma
Cupp, J. S., Wrede, J. E., Cherry, A. M., Arber, D. A., & George, T. I. (2008). Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 16(3), 296-300.

Gliosarcoma with melanocytic differentiation
Dulai, M. S., Moes, G. S., Briley, A. L., Galperin, I. B., Smyth, L., & Lehman, N. L. (2008). Gliosarcoma with melanocytic differentiation. ACTA NEUROPATHOLOGICA, 115(3), 357-361.

Array-based comparative genomic hybridization: clinical contexts for targeted and whole-genome designs
Aradhya, S., & Cherry, A. M. (2007). Array-based comparative genomic hybridization: clinical contexts for targeted and whole-genome designs. GENETICS IN MEDICINE, 9(9), 553-559.

Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation, and dysmorphic features
Aradhya, S., Manning, M. A., Splendore, A., & Cherry, A. M. (2007). Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation, and dysmorphic features. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 143A(13), 1431-1441.

Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900)
Vance, G. H., Kim, H., Hicks, G. A., Cherry, A. M., Higgins, R., & Dewald, G. W. (2007). Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900). LEUKEMIA RESEARCH, 31(5), 605-609.

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Moorman, A. V., Harrison, C. J., Buck, G. An., Richards, S. M., Secker-Walker, L. M., & Dewald, G. W. (2007). Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. BLOOD, 109(8), 3189-3197.

Molecular analysis of chromosomal rearrangements in mammalian cells after phi C31-mediated integration
Ehrhardt, A., Engler, J. A., Xu, H., Cherry, A. M., & Kay, M. A. (2006). Molecular analysis of chromosomal rearrangements in mammalian cells after phi C31-mediated integration. HUMAN GENE THERAPY, 17(11), 1077-1094.

Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus
Troxell, M. L., Bangs, C. D., Lawce, H. J., Galperin, I. B., Baiyee, D., & Cherry, A. M. (2006). Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 126(5), 709-716.

Identification of novel RUNXI (AMLI) translocation partner genes SH3D19, YTHDF2, and ZNF687 in acute myeloid leukemia
Nguyen, Td. T., Ma, L. N., Slovak, M. L., Bangs, C. D., Cherry, A. M., & Arber, D. A. (2006). Identification of novel RUNXI (AMLI) translocation partner genes SH3D19, YTHDF2, and ZNF687 in acute myeloid leukemia. GENES CHROMOSOMES & CANCER, 45(10), 918-932.

Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells
Lehman, N. L., Verschuren, E. W., Hsu, J. Y., Cherry, A. M., & Jackson, P. K. (2006). Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. CELL CYCLE, 5(14), 1569-1573.

Nablus mask-like facial syndrome is caused by a microdeletion of 8q detected by array-based comparative genomic hybridization.
Shieh, J. Tc., Aradhya, S., Novelli, A., Manning, M. A., Cherry, A. M., & Hoyme, H. E. (2006). Nablus mask-like facial syndrome is caused by a microdeletion of 8q detected by array-based comparative genomic hybridization. American journal of medical genetics. Part A, 140(12), 1267-1273.

CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1
Ling, J. Q., Li, T., Hu, J. F., Vu, T. H., Chen, H. L., & Hoffman, A. R. (2006). CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. SCIENCE, 312(5771), 269-272.

Triplication of 8p22-8p23 in a patient with features similar to Kabuki syndrome.
Shieh, J. Tc., Hudgins, L., Cherry, A. M., Shen, Z., & Hoyme, H. E. (2006). Triplication of 8p22-8p23 in a patient with features similar to Kabuki syndrome. American journal of medical genetics. Part A, 140(2), 170-173.

Fluorescence in situ hybridization investigation of cutaneous lesions in acute promyelocytic leukemia
Wrede, J. E., Sundram, U., Kohler, S., Cherry, A. M., Arber, D. A., & George, T. I. (2005). Fluorescence in situ hybridization investigation of cutaneous lesions in acute promyelocytic leukemia. MODERN PATHOLOGY, 18(12), 1569-1576.

Cytologic diagnosis of Burkitt lymphoma.
Troxell, M. L., Bangs, C. D., Cherry, A. M., Natkunam, Y., & Kong, C. S. (2005). Cytologic diagnosis of Burkitt lymphoma. Cancer, 105(5), 310-318.

A report of three patients with an interstitial deletion of chromosome 15q24
Cushman, L. J., Torres-Martinez, W., Cherry, A. M., Manning, M. A., Abdul-Rahman, O., & Vance, G. H. (2005). A report of three patients with an interstitial deletion of chromosome 15q24. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 137A(1), 65-71.

Low-grade B-cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements
George, T. I., Wrede, J. E., Bangs, C. D., Cherry, A. M., Warnke, R. A., & Arber, D. A. (2005). Low-grade B-cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. JOURNAL OF MOLECULAR DIAGNOSTICS, 7(3), 346-351.

Terminal deletion of 6p results in a recognizable phenotype
Lin, R. J., Cherry, A. M., Chen, K. C., Lyons, M., Hoyme, H. E., & Hudgins, L. (2005). Terminal deletion of 6p results in a recognizable phenotype. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 136A(2), 162-168.

Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: Case report and review of the literature
George, T. I., Jeng, M., Berquist, W., Cherry, A. M., Link, M. P., & Arber, D. A. (2005). Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: Case report and review of the literature. PEDIATRIC BLOOD & CANCER, 44(3), 270-276.

Mild developmental delay in terminal chromosome 6p deletion
Chen, K. M., Cherry, A. M., Hahn, J. S., & Enns, G. M. (2004). Mild developmental delay in terminal chromosome 6p deletion. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 129A(2), 201-205.

Terminal 22q deletion syndrome: A newly recognized cause of speech and language disability in the autism spectrum
Manning, M. A., Cassidy, S. B., Clericuzio, C., Cherry, A. M., Schwartz, S., & Hoyme, H. E. (2004). Terminal 22q deletion syndrome: A newly recognized cause of speech and language disability in the autism spectrum. PEDIATRICS, 114(2), 451-457.

Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study
Cherry, A. M., Brockman, S. R., Paternoster, S. F., Hicks, G. A., Neuberg, D., & DeWald, G. W. (2003). Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. LEUKEMIA RESEARCH, 27(12), 1085-1090.

Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression
Karlsson, A., Deb-Basu, D., Cherry, A., Turner, S., Ford, J., & Felsher, D. W. (2003). Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 100(17), 9974-9979.

Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma
Chen, G. K., Lacayo, N. J., Duran, G. E., Wang, Y., Bangs, C. D., & Sikic, B. I. (2002). Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma. GENES CHROMOSOMES & CANCER, 34(4), 372-383.

FISHing for answers: the use of molecular cytogenetic techniques in adolescent medicine practice.
Lin, R. J., Cherry, A. M., Bangs, C. D., & Hoyme, H. E. (2002). FISHing for answers: the use of molecular cytogenetic techniques in adolescent medicine practice. Adolescent medicine (Philadelphia, Pa.), 13(2), 305-?.

Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation
Suryanarayan, K., Natkunam, Y., Berry, G., Bangs, C. D., Cherry, A., & Dahl, G. (2001). Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(7), 452-455.

A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia
Cherry, A. M., Bangs, C. D., Jones, P., Hall, S., & Natkunam, Y. (2001). A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia. CANCER GENETICS AND CYTOGENETICS, 129(2), 155-160.

Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
Natkunam, Y., Cherry, A. M., & Cornbleet, P. J. (2001). Natural killer cell precursor acute lymphoma/leukemia presenting in an infant. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 125(3), 413-418.

Spindle cell lipoma of the foot and the application of CD34 immunohistochemistry to atypical lipomatous tumors in unusual locations
Austin, C. D., Tiessen, J. R., Gopalan, A., Williams, J. M., Bangs, C. D., & Rouse, R. V. (2000). Spindle cell lipoma of the foot and the application of CD34 immunohistochemistry to atypical lipomatous tumors in unusual locations. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 8(3), 222-227.

Blastic/blastoid transformation of follicular lymphoma - Immunohistologic and molecular analyses of five cases
Natkunam, Y., Warnke, R. A., Zehnder, J. L., Jones, C. D., Milatovich-Cherry, A., & Cornbleet, P. J. (2000). Blastic/blastoid transformation of follicular lymphoma - Immunohistologic and molecular analyses of five cases. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 24(4), 525-534.

Compound genetic factors as a cause of male infertility
Black, L. D., Nudell, D. M., Cha, I., Cherry, A. M., & Turek, P. J. (2000). Compound genetic factors as a cause of male infertility. HUMAN REPRODUCTION, 15(2), 449-451.

Human endothelial cell life extension by telomerase expression
Yang, J. W., Chang, E., Cherry, A. M., Bangs, C. D., Oei, Y., & Herron, G. S. (1999). Human endothelial cell life extension by telomerase expression. JOURNAL OF BIOLOGICAL CHEMISTRY, 274(37), 26141-26148.

Partial trisomy 1q with growth hormone deficiency and normal intelligence
Schorry, E. K., Dietrich, K. N., Saal, H. M., Blough, R. I., Dey, S., & Milatovich-Cherry, A. (1998). Partial trisomy 1q with growth hormone deficiency and normal intelligence. AMERICAN JOURNAL OF MEDICAL GENETICS, 77(4), 257-260.